December 18, 2025
1 min read

Trump’s marijuana reclassification could boost research, broaden access

President Trump on Thursday signed an executive order directing the federal government to reclassify marijuana as a Schedule III substance, marking a major milestone in American drug policy and choosing sides in the debate between advocates for more research and drug policy hawks.

Under the new classification, marijuana will remain an illegal drug under federal law. But the move could facilitate additional research into cannabis, federal officials said, even as others warned it would also boost the marijuana industry by allowing major tax breaks that were prohibited under the substance’s current classification. 

Read the rest…

Leave a Reply

Your email address will not be published.

Previous Story

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot

Next Story

Facing federal hostility, supervised consumption site points to 1,900 overdose reversals

Previous Story

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot

Next Story

Facing federal hostility, supervised consumption site points to 1,900 overdose reversals

Latest from Blog

Go toTop